Sunpointe LLC Purchases Shares of 402 Axon Enterprise, Inc $AXON

Sunpointe LLC acquired a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 402 shares of the biotechnology company's stock, valued at approximately $333,000.

A number of other institutional investors also recently made changes to their positions in AXON. TCTC Holdings LLC lifted its holdings in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after purchasing an additional 24 shares during the last quarter. Fourth Dimension Wealth LLC acquired a new position in Axon Enterprise in the 4th quarter valued at $30,000. Bartlett & CO. Wealth Management LLC grew its holdings in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after buying an additional 33 shares in the last quarter. Banque Transatlantique SA bought a new position in Axon Enterprise during the 1st quarter worth $31,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth $32,000. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $751.81 on Thursday. The stock's 50-day moving average is $758.40 and its 200-day moving average is $690.85. Axon Enterprise, Inc has a 1-year low of $380.51 and a 1-year high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock has a market cap of $59.02 billion, a P/E ratio of 185.63, a price-to-earnings-growth ratio of 27.55 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company's revenue was up 32.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In related news, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares of the company's stock, valued at $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the completion of the sale, the chief executive officer owned 3,053,982 shares in the company, valued at $2,538,744,696.78. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,932 shares of company stock worth $34,408,816 over the last 90 days. Company insiders own 4.40% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on AXON. Zacks Research downgraded shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, September 2nd. JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday, July 17th. UBS Group reaffirmed a "neutral" rating and set a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Wolfe Research initiated coverage on Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating for the company. Finally, Raymond James Financial reissued an "outperform" rating and set a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $837.69.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.